SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma to acquire significant stake in Adcock Ingram

13 Oct 2025 Evaluate

Natco Pharma is planning to acquire significant stake in 135-year-old South African pharmaceutical giant Adcock Ingram. The South African Rand 4.2-billion deal will see Adcock Ingram becoming a privately-held entity co-owned by Natco and Bidvest, which will remain the majority shareholder in the group.

A meeting of shareholders of Adcock Ingram approved Natco's proposal to acquire all the ordinary shares in the company. Natco Pharma will acquire all the ordinary shares in Adcock Ingram through its subsidiary -- Natco Pharma South Africa. 

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

1118.95 31.25 (2.87%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×